Paper7829869
Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes.
Vowells SJ and 4 others. J Immunol Methods, 1995. Cited by 342 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. Papers, record 7829869. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7829869
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Flow Cytometry | Major topic |
| Fluorescent Dyes | Major topic |
| Granulocytes | Major topic |
| Granulomatous Disease, Chronic | Major topic |
| Respiratory Burst | Major topic |
| Fluoresceins | |
| Humans | |
| Leukocyte Transfusion | |
| Rhodamines |
Source PubMed
Cited by106
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 342 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42758005 | Human inborn errors of the phagocyte respiratory burst: Chronic granulomatous disease and beyond. | J Hum Immun | 2026 | https://conductscience.org/library/papers/42758005 | PubMed |
| 42575992 | Standardized assays for evaluating superoxide dismutase-like and catalase-like activities of nanozymes. | Nat Protoc | 2026 | https://conductscience.org/library/papers/42575992 | PubMed |
| 40748410 | β-Actin Deficiency in Baraitser-Winter Syndrome Type 1 Disrupts T-Cell Function and Immune Regulation: Implications for Targeted Therapy in Actinopathies. | J Clin Immunol | 2025 | https://conductscience.org/library/papers/40748410 | PubMed |
| 40418478 | DCFDA Assay for Oxidative Stress Measurement in Fluorometer. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40418478 | PubMed |
| 39124702 | Diagnosis of Chronic Granulomatous Disease: Strengths and Challenges in the Genomic Era. | J Clin Med | 2024 | https://conductscience.org/library/papers/39124702 | PubMed |
| 39072316 | Flow cytometry-based diagnostic approach for inborn errors of immunity: experience from Algeria. | Front Immunol | 2024 | https://conductscience.org/library/papers/39072316 | PubMed |
| 38329126 | Attenuation of HOIL-1L ligase activity promotes systemic autoimmune disorders by augmenting linear ubiquitin signaling. | JCI Insight | 2024 | https://conductscience.org/library/papers/38329126 | PubMed |
| 38152406 | Case Report: The leopard sign as a potential characteristic of chronic granulomatous disease-associated colitis, unrelated to colitis severity. | Front Immunol | 2023 | https://conductscience.org/library/papers/38152406 | PubMed |
| 37764077 | Chronic Granulomatous Disease (CGD): Commonly Associated Pathogens, Diagnosis and Treatment. | Microorganisms | 2023 | https://conductscience.org/library/papers/37764077 | PubMed |
| 37580467 | Inhibition of CysLTR1 reduces the levels of aggregated proteins in retinal pigment epithelial cells. | Sci Rep | 2023 | https://conductscience.org/library/papers/37580467 | PubMed |
| 35796921 | Variant Type X91+ Chronic Granulomatous Disease: Clinical and Molecular Characterization in a Chinese Cohort. | J Clin Immunol | 2022 | https://conductscience.org/library/papers/35796921 | PubMed |
| 35790794 | Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model. | Gene Ther | 2023 | https://conductscience.org/library/papers/35790794 | PubMed |
| 35549996 | Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre. | Orphanet J Rare Dis | 2022 | https://conductscience.org/library/papers/35549996 | PubMed |
| 35230826 | Albumin Nanoparticle Endocytosing Subset of Neutrophils for Precision Therapeutic Targeting of Inflammatory Tissue Injury. | ACS Nano | 2022 | https://conductscience.org/library/papers/35230826 | PubMed |
| 33707834 | Clinical and Laboratory Profiles of 17 Cases of Chronic Granulomatous Disease in North India. | Indian J Hematol Blood Transfus | 2021 | https://conductscience.org/library/papers/33707834 | PubMed |
| 32838757 | Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib. | Orphanet J Rare Dis | 2020 | https://conductscience.org/library/papers/32838757 | PubMed |
| 32506450 | Late diagnosis of chronic granulomatous disease. | Clin Exp Immunol | 2020 | https://conductscience.org/library/papers/32506450 | PubMed |
| 32281309 | A novel variant in the neutrophil cytosolic factor 2 (NCF2) gene results in severe disseminated BCG infectious disease: A clinical report and literature review. | Mol Genet Genomic Med | 2020 | https://conductscience.org/library/papers/32281309 | PubMed |
| 32040803 | Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease. | J Clin Immunol | 2020 | https://conductscience.org/library/papers/32040803 | PubMed |
| 31832070 | A novel mutation in NCF2 resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease. | Allergy Asthma Clin Immunol | 2019 | https://conductscience.org/library/papers/31832070 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7829869
GET https://conductscience.org/api/papers/v1/7829869/cited_by?page=2